Statistical analysis
We selected a sample size of 220 participants in the nOPV2 group, with a placebo control group with half that number of participants (n=110), to provide sufficient power to assess the immunogenicity of the candidate vaccines on the basis of previous studies. In a study done in India in 2008, before the cessation of OPV2 usage, Sutter and colleagues